A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

NCT02741388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma

Interventions

DRUG: selinexor
DRUG: Rituximab
DRUG: Dexamethasone
DRUG: Oxaliplatin
DRUG: Cisplatin
DRUG: Cytarabine
DRUG: Gemcitabine

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]